Fidelity Investments
PRCT icon

Fidelity Investments’s Procept Biorobotics PRCT Stock Holding History

Fidelity Investments’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.6M Sell
1,444,878
-17,026
-1% -$426K ﹤0.01% 1692
2026
Q1 		$36.6M Sell
1,461,904
-3,191,207
-69% -$89.9M ﹤0.01% 1546
2025
Q4 		$146M Sell
4,653,111
-3,382,944
-42% -$112M 0.01% 1009
2025
Q3 		$287M Buy
8,036,055
+236,402
+3% +$10.8M 0.01% 707
2025
Q2 		$449M Sell
7,799,653
-423,035
-5% -$23.9M 0.03% 525
2025
Q1 		$479M Buy
8,222,688
+63,480
+0.8% +$4.33M 0.03% 469
2024
Q4 		$657M Buy
8,159,208
+866,328
+12% +$74M 0.04% 376
2024
Q3 		$584M Buy
7,292,880
+3,070
+0% +$218K 0.04% 423
2024
Q2 		$445M Sell
7,289,810
-234,067
-3% -$13.9M 0.03% 488
2024
Q1 		$372M Buy
7,523,877
+162,033
+2% +$7.71M 0.03% 553
2023
Q4 		$309M Sell
7,361,844
-191,616
-3% -$6.53M 0.02% 583
2023
Q3 		$248M Buy
7,553,460
+870,364
+13% +$29.7M 0.02% 617
2023
Q2 		$236M Sell
6,683,096
-46,777
-0.7% -$1.55M 0.02% 661
2023
Q1 		$191M Buy
6,729,873
+181,948
+3% +$6.42M 0.02% 722
2022
Q4 		$272M Buy
6,547,925
+91,609
+1% +$3.93M 0.03% 584
2022
Q3 		$268M Buy
6,456,316
+471,345
+8% +$18.8M 0.03% 566
2022
Q2 		$196M Buy
5,984,971
+1,032,091
+21% +$37.5M 0.02% 696
2022
Q1 		$173M Buy
4,952,880
+1,078,877
+28% +$26M 0.01% 846
2021
Q4 		$93.6M Buy
3,874,003
+502,838
+15% +$18.6M 0.01% 1125
2021
Q3 		$119M Buy
+3,371,165
New +$129M 0.01% 1024

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments's PRCT Position: Q2 2026 in Review

Fidelity Investments reduced its Procept Biorobotics (PRCT) stake by 1.2% in Q2 2026, selling an estimated $426K and leaving 1,444,878 shares worth $32.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1692.

Fidelity Investments first reported a position in PRCT in Q3 2021 and has held it in 20 quarters since. The position peaked at $657M in Q4 2024. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Fidelity Investments held 1,444,878 shares of Procept Biorobotics worth $32.6M as of Q2 2026.
  • Fidelity Investments sold 17,026 Procept Biorobotics shares in Q2 2026, an estimated $426K.
  • Procept Biorobotics made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #1692 holding.
  • Fidelity Investments first reported a position in Procept Biorobotics in Q3 2021 and has held it in 20 quarters since.
  • Fidelity Investments's Procept Biorobotics position peaked at $657M in Q4 2024.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.